Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients. Mediterr J Hematol Infect Dis [Internet]. 2022 Jun. 29 [cited 2026 Apr. 17];14(1):e2022056. Available from: https://www.mjhid.org/mjhid/article/view/4990